\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/c\ \(14\)\
\-\ multiple\\ mr\\ images\\ demonstrate\\ a\\ dumb\\-bell\\-shaped\\ mass\\ at\\ the\\ level\\ of\\ the\\ left\\ jugular\\ foramen\\,\\ fairly\\ isointense\\ to\\ brain\\ on\\ both\\ t1\\ and\\ t2\\ weighted\\ images\\,\\ which\\ demonstrate\\ homogeneous\\ enhancement\\ on\\ t1\\-weighted\\ images\\ obtained\\ after\\ the\\ iv\\ administration\\ of\\ gadolinium\\-dtpa\\ contrast\\ material\\.\\ \\ it\\ has\\ mass\\ effect\\ on\\ the\\ underlying\\ medulla\\.\\ \\ it\\ also\\ has\\ thickened\\,\\ enhancing\\,\\ \\"dural\\ tail\\.\\"\ \(0\)\
\-\ non\\-contrast\\ ct\\ images\\ demonstrate\\ fairly\\ diffuse\\ calcification\\ throughout\\ the\\ mass\\.\ \(0\)\
\-\ jugular\\ foramen\\ mass\\ \\(unknown\\;\\ patient\\ underwent\\ surgery\\ and\\ we\\ are\\ awaiting\\ the\\ results\\ of\\ pathologic\\ evaluation\\)\ \(1\)\
\-\ meningioma\ \(167\)\
\-\ nerve\\ sheath\\ tumor\\ \\(schwannoma\\)\ \(1\)\
\-\ less\\ likely\\:\ \(2\)\
\-\ paraganglioma\ \(36\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ lymphoma\ \(373\)\
\-\ 26\\ year\\-old\\ man\\,\\ detailed\\ history\\ withheld\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ fairly\\:\\ 0\\.08489586329146065\ \(0\)\
\-\ jugular\\:\\ 0\\.08311009183963308\ \(0\)\
\-\ dumb\\-bell\\-shaped\\:\\ 0\\.07470778325395337\ \(0\)\
\-\ foramen\\:\\ 0\\.06914101653511869\ \(0\)\
\-\ gadolinium\\-dtpa\\:\\ 0\\.06295952595632719\ \(0\)\
\-\ images\\:\\ 0\\.055568267523706916\ \(0\)\
\-\ detailed\\:\\ 0\\.05297092429241492\ \(0\)\
\-\ withheld\\:\\ 0\\.05234289063009525\ \(0\)\
\-\ n\\/c\\:\\ 0\\.0502131073395791\ \(0\)\
\-\ demonstrate\\:\\ 0\\.04999454596609426\ \(0\)\
\-\ awaiting\\:\\ 0\\.04890674564612775\ \(0\)\
\-\ medulla\\:\\ 0\\.047775123674733494\ \(0\)\
\-\ paraganglioma\\:\\ 0\\.044823372028392684\ \(0\)\
\-\ mass\\:\\ 0\\.0402868137948327\ \(0\)\
\-\ tail\\:\\ 0\\.03986986915078972\ \(0\)\
\-\ sheath\\:\\ 0\\.03986986915078972\ \(0\)\
\-\ t1\\-weighted\\:\\ 0\\.0397320681264526\ \(0\)\
\-\ we\\:\\ 0\\.038118900935849055\ \(0\)\
\-\ isointense\\:\\ 0\\.03559659243326473\ \(0\)\
\-\ non\\-contrast\\:\\ 0\\.03534853834597564\ \(0\)\
\-\ dural\\:\\ 0\\.035107538894106706\ \(0\)\
\-\ homogeneous\\:\\ 0\\.03427825253814266\ \(0\)\
\-\ 26\\:\\ 0\\.033522932369532424\ \(0\)\
\-\ schwannoma\\:\\ 0\\.03307511473076649\ \(0\)\
\-\ it\\:\\ 0\\.03255675228022062\ \(0\)\
\-\ thickened\\:\\ 0\\.03247382883269629\ \(0\)\
\-\ material\\:\\ 0\\.03235852669663036\ \(0\)\
\-\ pathologic\\:\\ 0\\.031697835667226025\ \(0\)\
\-\ weighted\\:\\ 0\\.03148857623849406\ \(0\)\
\-\ underlying\\:\\ 0\\.03103582058871796\ \(0\)\
\-\ administration\\:\\ 0\\.030064917499179406\ \(0\)\
\-\ results\\:\\ 0\\.029233410245293617\ \(0\)\
\-\ unknown\\:\\ 0\\.028261690683258532\ \(0\)\
\-\ meningioma\\:\\ 0\\.027848214715720975\ \(0\)\
\-\ has\\:\\ 0\\.027198304584648777\ \(0\)\
\-\ throughout\\:\\ 0\\.02710802818898243\ \(0\)\
\-\ year\\-old\\:\\ 0\\.02659970018388319\ \(0\)\
\-\ iv\\:\\ 0\\.026427329978483845\ \(0\)\
\-\ calcification\\:\\ 0\\.026286318800484144\ \(0\)\
\-\ nerve\\:\\ 0\\.026092763783790728\ \(0\)\
\-\ obtained\\:\\ 0\\.02574462797240544\ \(0\)\
\-\ effect\\:\\ 0\\.02564032417855292\ \(0\)\
\-\ underwent\\:\\ 0\\.024849118944730672\ \(0\)\
\-\ less\\:\\ 0\\.02452491529087019\ \(0\)\
\-\ mr\\:\\ 0\\.023010165016495204\ \(0\)\
\-\ t1\\:\\ 0\\.022953352001900372\ \(0\)\
\-\ enhancing\\:\\ 0\\.02271147061766745\ \(0\)\
\-\ diffuse\\:\\ 0\\.021923791698095888\ \(0\)\
\-\ brain\\:\\ 0\\.021791114604260694\ \(0\)\
\-\ evaluation\\:\\ 0\\.02103592199853227\ \(0\)\
\-\ level\\:\\ 0\\.020871940912262136\ \(0\)\
\-\ lymphoma\\:\\ 0\\.020696598596521065\ \(0\)\
\-\ t2\\:\\ 0\\.020496514989409763\ \(0\)\
\-\ likely\\:\\ 0\\.020426186151997087\ \(0\)\
\-\ enhancement\\:\\ 0\\.01941092174680539\ \(0\)\
\-\ both\\:\\ 0\\.018493220260051877\ \(0\)\
\-\ on\\:\\ 0\\.018404008788951563\ \(0\)\
\-\ metastatic\\:\\ 0\\.018229740708610935\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.01779775455620184\ \(0\)\
\-\ surgery\\:\\ 0\\.017584737833561653\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.017455504254086804\ \(0\)\
\-\ \\;\\:\\ 0\\.017164586342818592\ \(0\)\
\-\ man\\:\\ 0\\.017126541043135587\ \(0\)\
\-\ tumor\\:\\ 0\\.01688332458992213\ \(0\)\
\-\ contrast\\:\\ 0\\.016209963447524622\ \(0\)\
\-\ multiple\\:\\ 0\\.015252593249824312\ \(0\)\
\-\ after\\:\\ 0\\.014983061039061038\ \(0\)\
\-\ also\\:\\ 0\\.014276437234492808\ \(0\)\
\-\ which\\:\\ 0\\.013518174468157193\ \(0\)\
\-\ \\(\\:\\ 0\\.012243419088878991\ \(0\)\
\-\ \\)\\:\\ 0\\.012093859188361103\ \(0\)\
\-\ disease\\:\\ 0\\.0118367588238619\ \(0\)\
\-\ \\,\\:\\ 0\\.01147076548802065\ \(0\)\
\-\ ct\\:\\ 0\\.010129691977898668\ \(0\)\
\-\ history\\:\\ 0\\.010001818116161723\ \(0\)\
\-\ are\\:\\ 0\\.00987181247906442\ \(0\)\
\-\ at\\:\\ 0\\.009811552142640957\ \(0\)\
\-\ \\:\\:\\ 0\\.00957860013551411\ \(0\)\
\-\ left\\:\\ 0\\.008102587027736566\ \(0\)\
\-\ patient\\:\\ 0\\.007259253651833796\ \(0\)\
\-\ the\\:\\ 0\\.007029624645947075\ \(0\)\
\-\ to\\:\\ 0\\.0036192212579914088\ \(0\)\
\-\ a\\:\\ 0\\.0033610152696491634\ \(0\)\
\-\ and\\:\\ 0\\.0030510000971562447\ \(0\)\
\-\ of\\:\\ 0\\.0029619610372369942\ \(0\)\
\-\ \\.\\:\\ 0\\.001203374104994789\ \(0\)\
